EBV as the "gluten of MS" hypothesis provides a rationale for trialing antiviral therapies

Mult Scler Relat Disord. 2022 Aug:64:104007. doi: 10.1016/j.msard.2022.104007. Epub 2022 Jul 1.
No abstract available

Keywords: Antivirals; Epstein-Barr virus; Multiple sclerosis.

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / drug therapy
  • Glutens
  • Herpesvirus 4, Human
  • Humans
  • Multiple Sclerosis* / drug therapy

Substances

  • Antiviral Agents
  • Glutens